Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Fintech World Post.
Press releases published on June 13, 2025

JBDI Holdings Announces Results of Annual General Meeting
SINGAPORE, June 13, 2025 (GLOBE NEWSWIRE) -- JBDI Holdings Limited (“JBDI” or the “Company”) (Nasdaq: JBDI), a Singapore-based company, today announced that all the proposed resolutions submitted for shareholder approval set out in the notice of its Annual …

Co-Founder of MidCap Howard Widra to Retire at the End of 2026
BETHESDA, Md., June 13, 2025 (GLOBE NEWSWIRE) -- MidCap Financial (“MidCap”) today announced that Howard Widra, Co-Founder of MidCap and Partner at MidCap’s investment manager, Apollo Global Management, Inc. (“Apollo”), will retire from MidCap and Apollo …

180 Degree Capital Corp. Notes Filing of Updated Preliminary Joint Proxy Statement/Prospectus for Proposed Business Combination With Mount Logan Capital Inc.
MONTCLAIR, N.J., June 13, 2025 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) (“180 Degree Capital”) today noted the filing of an amended preliminary joint proxy statement/prospectus on Schedule 14A with the Securities and Exchange Commission …

Taseko Annual General Meeting Voting Results
VANCOUVER, British Columbia, June 13, 2025 (GLOBE NEWSWIRE) -- Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) (“Taseko” or the "Company") announces the voting results from its 2025 Annual General Meeting held Thursday, June 12, 2025 in …

June 2025 Letter to Shareholders of Nvni Group Limited
~ Building on a Strong Foundation through Operational Progress and Strategic Initiatives ~ NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading acquirer of private B2B SaaS companies in …

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease
– The International Society for Stem Cell Research (“ISSCR”) 2025 Annual Meeting is the world’s foremost gathering of stem cell and regenerative medicine leaders – – Updated data presented at ISSCR 2025 demonstrates >50% improvement in pain and function in …

Phillips Edison & Company Announces Pricing of Offering of $350 Million Aggregate Principal Amount of 5.250% Senior Unsecured Notes Due 2032
CINCINNATI, June 13, 2025 (GLOBE NEWSWIRE) -- Phillips Edison …

Peyto Exploration & Development Corp. Announces Retirement of a Director and Confirms Monthly Dividend for July 15, 2025
CALGARY, Alberta, June 13, 2025 (GLOBE NEWSWIRE) -- Peyto Exploration …

Senmiao Technology Signs a Strategic Cooperation Agreement with Changsha Yipeng to Develop an AI-Backed Data Management System for Online Ride-Hailing Service Providers
CHENGDU, China, June 13, 2025 (GLOBE NEWSWIRE) -- Senmiao Technology Limited (“Senmiao” or the “Company”) (Nasdaq: AIHS), a financing and servicing company focused on the online ride-hailing industry in China, today announced that it has signed a strategic …

Sunrise Realty Trust Announces Dividend for the Second Quarter 2025
WEST PALM BEACH, Fla., June 13, 2025 (GLOBE NEWSWIRE) -- Sunrise Realty Trust, Inc. (Nasdaq: SUNS) (“SUNS”), a lender on the TCG Real Estate platform, today announced its dividend for the quarter ending June 30, 2025. The Board of Directors of SUNS …

reAlpha Expands Homebuying Platform into Texas, Marking First Step in National Realty Rollout
DUBLIN, Ohio, June 13, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), an AI-powered real estate technology company, today announced the expansion of its platform into Texas1 with the launch of real estate brokerage …

Advanced Flower Capital Announces Dividend for the Second Quarter 2025
WEST PALM BEACH, Fla., June 13, 2025 (GLOBE NEWSWIRE) -- Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC” or the “Company”) today announced its dividend for the quarter ending June 30, 2025. The Board of Directors of AFC declared a quarterly dividend of …

New Wave Announces Investment in Cartwheel Robotics, an Advanced Robotics Company Seeking to Build Humanoids for Humans
Vancouver, BC, June 13, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp. (“New Wave” or the “Company”) (CSE:NWAI, FWB:0XM0, OTCPK:TRMNF) is pleased to announce that it has made a strategic investment of US$150,000 into Cartwheel Robotics Inc. (“Cartwheel …

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
LONDON, June 13, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the …

Melco Announces Appointment of New Independent Non-Executive Director
MACAU, June 13, 2025 (GLOBE NEWSWIRE) -- Melco Resorts …

Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 Congress
– ARV-393 demonstrated significant single-agent activity in models of nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (also known as AITL) and transformed follicular lymphoma – – In combination with small molecule inhibitors, ARV-393 …

Baker Hughes Announces Dates for Second-quarter Earnings Release and Webcast
HOUSTON and LONDON, June 13, 2025 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR) will announce the results of the second quarter ending June 30, 2025, via press release at 5 p.m. Eastern Time (4 p.m. Central Time) on Tuesday, July 22, 2025. A webcast to …

ORLADEYO® (berotralstat) Approved in Colombia
RESEARCH TRIANGLE PARK, N.C., June 13, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the National Institute of Drug and Food Surveillance (INVIMA) in Colombia has granted approval for oral, once-daily ORLADEYO …

Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 Supporting Differentiated Profile in Sickle Cell Disease (SCD) at European Hematology Association (EHA) 2025 Congress
Updated Data from 17 Patients Consistent with Previously Presented Data; All Patients Treated with BEAM-101 Achieved Hemoglobin F (HbF) Induction of >60%, Hemoglobin S (HbS) Reduction to <40%, and Resolution of Anemia Patients Required a Median of One …

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds
TORONTO, June 13, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is …